PeptidePicker
Home/Peptides/FOXO4-DRI
Anti-AgingResearch

FOXO4-DRI

Also known as: FOXO4-D-Retro-Inverso · Proxofim

A senolytic peptide that selectively forces zombie (senescent) cells to self-destruct, reducing systemic inflammation and reversing aging markers.

Dr. Sarah Mitchell

Reviewed by Dr. Sarah Mitchell, PharmD, BCPS

Lead Researcher · 12+ years in peptide therapeutics

Half-Life

~2–6 hours

Typical Dose

Varies (research protocols)

Administration

Subcutaneous injection

Mechanism of Action

Disrupts the FOXO4-p53 interaction that keeps senescent cells alive, forcing them into apoptosis while leaving healthy cells unaffected.

Key Research Areas

anti-agingsenolyticlongevitysenescent cells

Frequently Asked Questions

What is FOXO4-DRI?
A senolytic peptide that selectively forces zombie (senescent) cells to self-destruct, reducing systemic inflammation and reversing aging markers.
How does FOXO4-DRI work?
Disrupts the FOXO4-p53 interaction that keeps senescent cells alive, forcing them into apoptosis while leaving healthy cells unaffected.
What is the recommended dosage for FOXO4-DRI?
The typical research dosage is Varies (research protocols), administered via Subcutaneous injection. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of FOXO4-DRI?
The half-life of FOXO4-DRI is approximately ~2–6 hours. This affects dosing frequency and timing in research protocols.
Is FOXO4-DRI FDA approved?
FOXO4-DRI is currently classified as "Research" and is not FDA approved for general use. It is available for research purposes or through compounding pharmacies depending on your jurisdiction.

Research Disclaimer

The information provided about FOXO4-DRI is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.

Related Peptides in Anti-Aging